DRIO - DarioHealth Corp. (DRIO) Q4 2023 Earnings Call Transcript
2024-03-28 14:54:02 ET
DarioHealth Corp. (DRIO)
Q4 2023 Earnings Conference Call
March 28, 2024 08:30 ET
Company Participants
Kat Parrella - Investor Relations
Erez Raphael - Chief Executive Officer
Rick Anderson - President
Ofer Leidner - Co-Founder, Twill
Tomer Ben-Kiki - Co-Founder, Twill
Conference Call Participants
David Grossman - Stifel
Charles Padala - Lifesci Advisors
Presentation
Operator
Greetings and welcome to the DarioHealth Fourth Quarter 2023 Results Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Kat Parrella, Investor Relations Manager.
Kat Parrella
Thank you, operator and good morning, everybody. Thank you for joining us today for a discussion of DarioHealth's fourth quarter and full year 2023 financial results. Leading the call today will be Erez Raphael, CEO of DarioHealth. He'll be joined by Rick Anderson, President. After the prepared remarks, we will open the call for Q&A, where we will be joined by Twill co-founders, Tomer Ben-Kiki and Ofer Leidner. An audio recording and webcast replay for this call will also be available online as detailed in the press release invite for this call. For the benefit of those who may be listening to the replay or archived webcast, this call is being held on Thursday, March 28, 2024.
This morning, we issued a press release announcing our financial results for the fourth quarter and full year 2023, a copy of the release can be found on the Investor Relations page of DarioHealth's website. Actual events or results may differ materially from those projected as a result of changing market trends, reduced demand or the competitive nature of DarioHealth's industry. Such forward-looking statements and their implications may involve known and unknown risks, uncertainties and other factors that may cause actual results or performance to differ materially from those projected. The forward-looking statements discussed on this call are subject to other risks and uncertainties, including those discussed in the Risk Factors section and elsewhere in the company's full year 2023 annual report on Form 10-K. Additional information concerning factors that could cause results to differ materially from our forward-looking statements are described in greater detail on the company's press release issued this morning and in the company's other filings with the SEC....
DarioHealth Corp. (DRIO) Q4 2023 Earnings Call Transcript